← Back to All Filings
Guardant Health Director Alex M. Azar II Files Form 144 for 826 Shares
Guardant Health, Inc.
$GH144CIK: 0001576280
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Guardant Health, Inc. ($GH) Form 144 Filing • Insider: Alex M. Azar II (Director) • Proposed Sale: 826 shares (~$144,550) • Plan Date: 10b5-1 plan adopted on May 21, 2026 • Approx. Sale Date: September 16, 2026
Comprehensive Analysis
Guardant Health, Inc. (GH) Form 144 Notice of Proposed Sale
- Insider: Alex M. Azar II, Director
- Securities to be Sold: 826 shares of Common Stock
- Aggregate Market Value: $144,550.00
- Approximate Date of Sale: September 16, 2026
- Acquisition Origin: 826 shares acquired on September 12, 2026, via restricted stock lapse (equity compensation).
- Trading Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026.
- Significance Assessment: Low. The proposed transaction represents a minimal portion of the issuer's 134,196,170 outstanding shares and follows a pre-established 10b5-1 trading arrangement.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.